Insight into the Determinants of Exceptional Aging and Longevity (IDEAL) Project
Insight into the Determinants of Exceptional Aging and Longevity (IDEAL) Project
批准号:
8552542
负责人:
Luigi Ferrucci
金额:
$39.34万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至
关键词:
AffectAgeAgingAntioxidantsAreaAwardBehavioralBiological MarkersCharacteristicsChronic DiseaseContractsControl GroupsDiseaseDisease ResistanceElderlyEnrollmentEnvironmental Risk FactorGoalsHealthHealth PromotionHeritabilityHormonesImpaired cognitionIndividualInflammationInterventionLearningLifeLongevityMeasuresMethodsMissionNational Heart, Lung, and Blood InstituteOutcomeParticipantPathologyPersonsPhasePhysical FunctionPhysiologicalPhysiologyPopulationPreventionProcessRecruitment ActivityResearchRisk FactorsScreening procedureSurvivorsTimeTwin StudiesVisitWashingtonagedautonomic reflexbehavior measurementcohortdisabilityend of lifeexperiencefunctional declinehealthy aginginsightmacromoleculemeetingsoxidative damageresearch and development
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Studying an exceptionally rare well-aged population represents a logical progression for a new phase of the BLSA. By including a new cohort of participants who have aged exceptionally well, the BLSA will be able to utilize fully the extensive set of measures recently introduced in the study. In addition, the study of IDEAL aging is consistent with the original mission of the BLSA concerning the study of healthy aging, independent of the effects of disease. Despite excellent health at the time of enrollment only a small proportion of the nearly 500 current BLSA participants aged 80 years or older meet IDEAL criteria. By enrolling the IDEAL cohort in the BLSA their biologic, physiologic, behavioral and functional characteristics will be evaluated with using the same methods used with the current cohort who will serve as a type of control group. As is customary in the BLSA, we plan to follow this cohort for life with yearly visits.
STUDY AIMS
The first aim is to identify factors and characteristics that distinguish IDEAL from non IDEAL individuals. In the current BLSA, an extraordinarily wide range of information is collected on biomarkers, physiological measures, behavioral and environmental risk factors and functional and disease-related outcomes. We intend to compare the two groups to identify factors that discriminate IDEAL aging from non IDEAL aging individuals. The second aim is to identify physiological, environmental and behavioral characteristics that are risk factors for losing the IDEAL condition over several years or longer. We postulate that the mechanisms of extreme longevity probably differ from those associated with delay or escape from disease and disability. For example, we hypothesize that in older persons who escape diseases and disability, homeostatic mechanisms (integrity of anti-oxidant mechanisms, low level of oxidative damage to macromolecules, low inflammation, unimpaired autonomic reflexes, normal hormone levels etc.) are relatively intact, with little accumulated damage.
DESIGN
The operational definition of IDEAL aging is living until age 80 and meeting the current BLSA enrollment criteria which in brief requires the absence of chronic disease and conditions and mobility and cognitive impairment evaluated using a rigorous screening process. It can be conservatively estimated that approximately 1% of those 80 years or older are IDEAL aged individuals. IDEAL participants will be recruited from the Baltiore-Washington area, which has over 600,000 persons aged 80 years or older of whom an estimated 6,000 should be IDEAL candidates.
Enrollment of IDEAL participants in the BLSA is being conducted under an R&D contract, awarded to WESTAT. Recruitment is ongoing and the first few participants have been enrolled.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Temporary CARD Facility
-
批准号:10291099
-
项目类别:
-
资助金额:$3029.09万
-
财政年份:--
-
负责人:Luigi Ferrucci
-
依托单位:
THE INCHIANTI FOLLOW-UP STUDY-260012111
-
批准号:6828820
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Luigi Ferrucci
-
依托单位:
Characterization Of TGF-b Signaling In a B-cell Lymphoma Cell Line
-
批准号:8335774
-
项目类别:
-
资助金额:$30.19万
-
财政年份:--
-
负责人:Luigi Ferrucci
-
依托单位:
The VALIDATE study
-
批准号:8335795
-
项目类别:
-
资助金额:$10.68万
-
财政年份:--
-
负责人:Luigi Ferrucci
-
依托单位:
NINDS CCMF allocation
-
批准号:8557136
-
项目类别:
-
资助金额:$2204.6万
-
财政年份:--
-
负责人:Luigi Ferrucci
-
依托单位:
The BLSA Home Visit Program
-
批准号:7964134
-
项目类别:
-
资助金额:$8.22万
-
财政年份:--
-
负责人:Luigi Ferrucci
-
依托单位:
The Energetic Pathway to Disability in Older Persons
-
批准号:8736674
-
项目类别:
-
资助金额:$26.46万
-
财政年份:--
-
负责人:Luigi Ferrucci
-
依托单位:
The BLSA Home Visit Program
-
批准号:8552540
-
项目类别:
-
资助金额:$9.83万
-
财政年份:--
-
负责人:Luigi Ferrucci
-
依托单位:
NIGMS CCMF allocation
-
批准号:8744620
-
项目类别:
-
资助金额:$15.43万
-
财政年份:--
-
负责人:Luigi Ferrucci
-
依托单位:
NIA IRP Comparative Medicine Section
-
批准号:8736979
-
项目类别:
-
资助金额:$411.99万
-
财政年份:--
-
负责人:Luigi Ferrucci
-
依托单位:
NIA IRP Comparative Medicine Section
-
批准号:9550723
-
项目类别:
-
资助金额:$726.68万
-
财政年份:--
-
负责人:Luigi Ferrucci
-
依托单位:
NIBIB CCMF allocation
-
批准号:8933904
-
项目类别:
-
资助金额:$160.98万
-
财政年份:--
-
负责人:Luigi Ferrucci
-
依托单位:
Genetic Analysis Of Klotho In Diseases Of Aging
-
批准号:8335889
-
项目类别:
-
资助金额:$8.36万
-
财政年份:--
-
负责人:Luigi Ferrucci
-
依托单位:
The Aging Genome Association Study "AGE-GAIN"
-
批准号:8335996
-
项目类别:
-
资助金额:$27.4万
-
财政年份:--
-
负责人:Luigi Ferrucci
-
依托单位:
Structure-function relationship of NFkB p65
-
批准号:8335862
-
项目类别:
-
资助金额:$23.22万
-
财政年份:--
-
负责人:Luigi Ferrucci
-
依托单位:
The InChianti Study
-
批准号:9565909
-
项目类别:
-
资助金额:$16.36万
-
财政年份:--
-
负责人:Luigi Ferrucci
-
依托单位:
The InChianti Study
-
批准号:10012639
-
项目类别:
-
资助金额:$8.2万
-
财政年份:--
-
负责人:Luigi Ferrucci
-
依托单位:
Microbiome Projects in the Baltimore Longitudinal Study of Aging
-
批准号:10012638
-
项目类别:
-
资助金额:$8.2万
-
财政年份:--
-
负责人:Luigi Ferrucci
-
依托单位:
NINR CCMF allocation
-
批准号:8554738
-
项目类别:
-
资助金额:$91.39万
-
财政年份:--
-
负责人:Luigi Ferrucci
-
依托单位:
The Hallmarks of Aging: Assessing accumulation of DNA lesions with age using single cell DNA sequencing in GESTALT
-
批准号:10691058
-
项目类别:
-
资助金额:$1.15万
-
财政年份:--
-
负责人:Luigi Ferrucci
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: